David Hollander - 27 Feb 2024 Form 3 Insider Report for Revance Therapeutics, Inc.

Role
CMO & Global Therapeutics Lead
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
27 Feb 2024
Net transactions value
$0
Form type
3
Filing time
29 Feb 2024, 16:32:32 UTC
Previous filing
03 Oct 2023
Next filing
03 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RVNC Common Stock 108,853 27 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RVNC Stock Option (Right to buy) 27 Feb 2024 Common Stock 49,669 $24.65 Direct F1
holding RVNC Performance Stock Units 27 Feb 2024 Common Stock 120,000 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option shall vest over a period of four years commencing on October 17, 2022, with 25% vesting on the annual anniversary of the vesting commencement date and 1/48th vesting each month thereafter over the remaining three years, subject to Dr. Hollander's Continuous Service (as defined in the Plan) through each such vesting date.
F2 The performance-based restricted stock units (PSUs) granted to the reporting person on January 31, 2024 represent the right to receive, following vesting, a number of shares of Common Stock up to 150% of the number of PSUs. The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metric, as approved by the Company's Compensation Committee, over a four-year performance period, subject to time based service requirements and continuous employment with the Company through the vesting dates.
F3 The number of securities reported represents the maximum shares that can be earned.

Remarks:

Exhibit24, Power of Attorney, is attached.